JOSH ANDERSON has extensive experience handling the defense of class actions, appeals and complex, multi-party litigation in federal and state trial and appellate courts. With a passion for providing creative solutions to complicated legal issues, Josh has substantial experience in the areas of insurance, life sciences, pharmaceuticals and consumer fraud.
Josh’s litigation and relationship skills have earned him recognition from clients and peers. He has been recognized in The Best Lawyers in America (2020–2022). In 2017, he was named one of the BTI Client Service All-Stars, an elite group of lawyers whom world-leading corporate counsel recognize as client service leaders.
Josh’s cases and victories have been reported in The New York Times, The Wall Street Journal, The American Lawyer, The National Law Journal, Law360 and the Drug and Device Law blog. For example, the federal district court’s judgment in AstraZeneca AB v. Apotex Corp., 985 F. Supp. 2d 452 (S.D.N.Y. 2013), was described in Law 360’s article naming the firm number two on its list of Litigation Powerhouses for 2016 and in The National Law Journal’s article naming the firm to its 2014 Intellectual Property Hot List.